Kathryn S. Kolibaba: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

Polatuzumab vedotin or pinatuzumab vedotin plus rituximab in patients with relapsed or refractory non-Hodgkin lymphoma: final results from a phase 2 randomised study (ROMULUS)

Morschhauser, Franck, Flinn, Ian W, Advani, Ranjana, Sehn, Laurie H, Diefenbach, Catherine, Kolibaba, Kathryn, Press, Oliver W, Salles, Gilles, Tilly, Hervé, Chen, Andy I, Assouline, Sarit, Cheson, Br

Journal:

The Lancet Haematology

Year:

2019

Language:

english

File:

PDF, 683 KB

english, 2019

2

Efficacy of STI571, an Abl tyrosine kinase inhibitor, in conjunction with other antileukemic agents against Bcr-Ablâpositive cells

Thiesing, J. Tyler, Ohno-Jones, Sayuri, Kolibaba, Kathryn S., Druker, Brian J.

Journal:

Year:

2000

File:

PDF, 148 KB

2000

3

An open-label phase 2 trial of entospletinib in indolent non-Hodgkin lymphoma and mantle cell lymphoma

Andorsky, David J., Kolibaba, Kathryn S., Assouline, Sarit, Forero-Torres, Andres, Jones, Vicky, Klein, Leonard M., Patel-Donnelly, Dipti, Smith, Mitchell, Ye, Wei, Shi, Wen, Yasenchak, Christopher A.

Journal:

British Journal of Haematology

Year:

2018

Language:

english

File:

PDF, 209 KB

english, 2018

4

Polatuzumab vedotin in combination with immunochemotherapy in patients with previously untreated diffuse large B-cell lymphoma: an open-label, non-randomised, phase 1b–2 study

Tilly, Hervé, Morschhauser, Franck, Bartlett, Nancy L, Mehta, Amitkumar, Salles, Gilles, Haioun, Corinne, Munoz, Javier, Chen, Andy I, Kolibaba, Kathryn, Lu, Dan, Yan, Mark, Penuel, Elicia, Hirata, Ja

Journal:

The Lancet Oncology

Year:

2019

Language:

english

File:

PDF, 574 KB

english, 2019

5

Ublituximab (TG-1101), a novel glycoengineered anti-CD20 antibody, in combination with ibrutinib is safe and highly active in patients with relapsed and/or refractory chronic lymphocytic leukaemia: results of a phase 2 trial

Sharman, Jeff P., Farber, Charles M., Mahadevan, Daruka, Schreeder, Marshall T., Brooks, Heather D., Kolibaba, Kathryn S., Fanning, Suzanne, Klein, Leonard, Greenwald, Daniel R., Sportelli, Peter, Mis

Journal:

British Journal of Haematology

Year:

2017

Language:

english

File:

PDF, 226 KB

english, 2017

6

Extended dosing with CC-486 (oral azacitidine) in patients with myeloid malignancies

Savona, Michael R., Kolibaba, Kathryn, Conkling, Paul, Kingsley, Edwin C., Becerra, Carlos, Morris, John C., Rifkin, Robert M., Laille, Eric, Kellerman, Amy, Ukrainskyj, Stacey M., Dong, Qian, Skikne,

Journal:

American Journal of Hematology

Year:

2018

Language:

english

File:

PDF, 1.23 MB

english, 2018

7

Protein tyrosine kinases and cancer

Kathryn S Kolibaba, Brian J Druker

Journal:

Biochimica et Biophysica Acta (BBA) - Reviews on Cancer

Year:

1997

Language:

english

File:

PDF, 730 KB

english, 1997

8

CRKL Binding to BCR-ABL and BCR-ABL Transformation

Kolibaba, Kathryn S., Bhat, Arun, Heaney, Conor, Oda, Tsukasa, Druker, Brian J.

Journal:

Leukemia and Lymphoma

Year:

1999

Language:

english

File:

PDF, 1010 KB

english, 1999

9

Differences in Quality of Life Between Bendamustine-Rituximab and R-CHOP/R-CVP in Patients With Previously Untreated Advanced Indolent Non-Hodgkin Lymphoma or Mantle Cell Lymphoma

Burke, John M., van der Jagt, Richard H.C., Kahl, Brad S., Wood, Peter, Hawkins, Tim E., MacDonald, David, Hertzberg, Mark, Simpson, David, Craig, Michael, Kolibaba, Kathryn, Issa, Samar, Munteanu, Mi

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2016

Language:

english

File:

PDF, 1.27 MB

english, 2016

10

CaM Kinase IV Regulates Lineage Commitment and Survival of Erythroid Progenitors in a Non-Cell-Autonomous Manner

Gary A. Wayman, Melinda J. Walters, Kathryn Kolibaba, Thomas R. Soderling and Jan L. Christian

Journal:

The Journal of Cell Biology

Year:

2000

Language:

english

File:

PDF, 5.15 MB

english, 2000

11

Results of a Phase II trial of gemcitabine, mitoxantrone, and rituximab in relapsed or refractory mantle cell lymphoma

Lawrence E. Garbo, Patrick J. Flynn, Margaret A. MacRae, Mary A. Rauch, Yunfei Wang, Kathryn S. Kolibaba

Journal:

Investigational New Drugs

Year:

2009

Language:

english

File:

PDF, 142 KB

english, 2009

12

A phase 1 trial of SGN-CD70A in patients with CD70-positive diffuse large B cell lymphoma and mantle cell lymphoma

Phillips, Tycel, Barr, Paul M., Park, Steven I., Kolibaba, Kathryn, Caimi, Paolo F., Chhabra, Saurabh, Kingsley, Edwin C., Boyd, Thomas, Chen, Robert, Carret, Anne-Sophie, Gartner, Elaina M., Li, Hong

Journal:

Investigational New Drugs

Year:

2018

Language:

english

File:

PDF, 551 KB

english, 2018

13

Phase 1 Study of Alvocidib Followed by 7+3 (Cytarabine + Daunorubicin) in Newly Diagnosed Acute Myeloid Leukemia

Zeidner, Joshua F, Lee, Daniel J, Frattini, Mark G, Fine, Gil D, Costas, Judy, Kolibaba, Kathryn, Anthony, Stephen P, Bearss, David J., Smith, B. Douglas

Journal:

Clinical Cancer Research

Year:

2020

File:

PDF, 1.91 MB

2020

14

First-Line Treatment of Patients With Indolent Non-Hodgkin Lymphoma or Mantle-Cell Lymphoma With Bendamustine Plus Rituximab Versus R-CHOP or R-CVP: Results of the BRIGHT 5-Year Follow-Up Study

Flinn, Ian W., van der Jagt, Richard, Kahl, Brad, Wood, Peter, Hawkins, Tim, MacDonald, David, Simpson, David, Kolibaba, Kathryn, Issa, Samar, Chang, Julie, Trotman, Judith, Hallman, Doreen, Chen, Lin

Journal:

Journal of Clinical Oncology

Year:

2019

Language:

english

File:

PDF, 722 KB

english, 2019

To build up a library is to create a life. It’s never just a random collection of books.

— Carlos María Domínguez

Official channel

Z-Library Desktop Launcher

Z-Library Since 2009 support@z-lib.do

EnglishРусскийEspañolItalianoελληνικάاللغة العربيةBahasa IndonesiaBahasa Malaysiaहिन्दीDeutschFrançaisPortuguêsУкраїнськаPolski中文繁體中文日本語Tiếng ViệtAzərbaycan DiliՀայոց լեզուภาษาไทยTürk Diliქართველიবাংলাپښتوతెలుగుاردو한국어SrpskiБългарски